Thorne Healthtech

Thorne Healthtech ROE

Delisted

The Return on Equity (ROE) of Thorne Healthtech (THRN) as of Nov 10, 2026 is 10.81 %. In the previous year, Return on Equity (ROE) was 8.87 % — a change of 21.93% (higher).

ROE

10.81 %

YoY

21.93%

Last updated:

In 2022, Thorne Healthtech's return on equity (ROE) was 10.81 %, a 21.93% increase from the 8.87 % ROE in the previous year.

The Thorne Healthtech ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
16.42 USD
Jan 1, 2020
3.04 USD
Jan 1, 2021
8.87 USD
Jan 1, 2022
10.81 USD
The Thorne Healthtech ROE history
YEARROEYoY
10.81 %+21.93%
8.87 %+191.61%
3.04 %-81.48%
16.42 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Thorne Healthtech Stock analysis

What does Thorne Healthtech do? Thorne Healthtech Inc is a leading company in the health and wellness industry based in the USA. Founded in 1984 by Al Czap, a former Olympic champion and naturopath, Thorne Healthtech Inc has focused on producing high-quality dietary supplements. The history of Thorne Healthtech Inc began with the goal of improving people's health and well-being. The founder, Czap, believed that it was necessary to strengthen the body from the inside out to achieve long-term health. He started integrating naturopathic principles into his work and developing natural-based dietary supplements. Thorne Healthtech Inc's business model is based on the development and production of high-quality dietary supplements tailored to the needs of customers. The company has a strong research and development department that constantly develops new innovative products and improves existing ones. Thorne Healthtech Inc adheres to strict quality standards in manufacturing, and the products are produced under the supervision of experts. The company has divided itself into different divisions to offer customers a wide range of health products. One of the divisions is Performance Products, specifically tailored to athletes. This can include dietary supplements for post-workout recovery, collagen for joint health support, or supplements to enhance endurance and strength. Another division is Immune System Products. Here, Thorne Healthtech Inc offers a variety of dietary supplements designed to strengthen the immune system and protect the body against diseases and infections. This includes vitamins, herbs, minerals, and probiotic supplements. Another important area is Nutrient Supplements. Thorne Healthtech Inc produces a wide range of dietary supplements that can help provide the body with the necessary amount of nutrients. These include folic acid, magnesium, vitamin B12, and vitamin C. A particularly important area for the health industry is the Laboratory Tests sector. Thorne Healthtech Inc offers various tests for interested customers to better understand their health condition. These include tests for vitamins, minerals, probiotics, allergies, and more. In conclusion, Thorne Healthtech Inc is a company specialized in improving the physical and mental health of people through the production of high-quality dietary supplements. The company has a long history and extensive experience in naturopathy, and follows strict quality standards in product manufacturing. With a wide range of health and wellness products and excellent customer service, Thorne Healthtech Inc aims to support its customers in leading healthier lives. Thorne Healthtech is one of the most popular companies on Eulerpool.

ROE Details

Decoding Thorne Healthtech's Return on Equity (ROE)

Thorne Healthtech's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Thorne Healthtech's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Thorne Healthtech's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Thorne Healthtech’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Thorne Healthtech stock

Return on Equity (ROE) of Thorne Healthtech is 10.81 % in 2022.

Return on Equity (ROE) of Thorne Healthtech changed from 8.87 % to 10.81 %, representing a 21.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Thorne Healthtech since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Thorne Healthtech with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Thorne Healthtech

All Key Metrics — Thorne Healthtech